These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 25170220

  • 21. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y.
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [Abstract] [Full Text] [Related]

  • 22. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A.
    Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
    [Abstract] [Full Text] [Related]

  • 23. Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.
    Liu H, Du L, Wen Z, Yang Y, Li J, Wang L, Zhang X, Liu Y, Dong Z, Li W, Zheng G, Wang C.
    Int J Colorectal Dis; 2013 May; 28(5):697-703. PubMed ID: 23474644
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Zhou T, Zhang G, Liu Z, Xia S, Tian H.
    Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
    [Abstract] [Full Text] [Related]

  • 25. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L, Meng T, Yang XH, Sayim P, Lei C, Jin B, Ge L, Wang HJ.
    Cancer Biomark; 2018 Jan; 22(2):283-299. PubMed ID: 29630521
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT, Göğebakan B, Bayram S, Batmacı CY, Öztuzcu S.
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [Abstract] [Full Text] [Related]

  • 27. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [Abstract] [Full Text] [Related]

  • 28. Clinical significance of miR-22 expression in patients with colorectal cancer.
    Zhang G, Xia S, Tian H, Liu Z, Zhou T.
    Med Oncol; 2012 Dec; 29(5):3108-12. PubMed ID: 22492279
    [Abstract] [Full Text] [Related]

  • 29. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y, Xiao W, Jiang X, Li H.
    Cancer Biomark; 2019 Dec; 26(2):229-237. PubMed ID: 31524145
    [Abstract] [Full Text] [Related]

  • 30. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW, Liu N, Chen S, Wang Y, Zhang ZX, Sun YY, Qiu GB, Fu WN.
    Diagn Pathol; 2015 Apr 03; 10():22. PubMed ID: 25879432
    [Abstract] [Full Text] [Related]

  • 31. miR-1260b is a Potential Prognostic Biomarker in Colorectal Cancer.
    Liu DR, Guan QL, Gao MT, Jiang L, Kang HX.
    Med Sci Monit; 2016 Jul 11; 22():2417-23. PubMed ID: 27399918
    [Abstract] [Full Text] [Related]

  • 32. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
    Ma J, Zhang S, Hu Y, Li X, Yuan F, Sun D, Wang L, Zhang F, Chen G, Cui P.
    Medicine (Baltimore); 2017 Oct 11; 96(42):e7011. PubMed ID: 29049167
    [Abstract] [Full Text] [Related]

  • 33. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y, Ren J, Liu K, Tang LM.
    World J Gastroenterol; 2015 Mar 14; 21(10):2949-58. PubMed ID: 25780292
    [Abstract] [Full Text] [Related]

  • 34. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D, Li K, Zhu K, Yan R, Dang C.
    Cancer Biol Ther; 2015 Mar 14; 16(2):268-75. PubMed ID: 25629978
    [Abstract] [Full Text] [Related]

  • 35. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S, Yi XM, Zhou WQ, Cheng W, Ge JP, Zhang ZY.
    Int J Clin Exp Pathol; 2015 Mar 14; 8(11):14335-44. PubMed ID: 26823749
    [Abstract] [Full Text] [Related]

  • 36. Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.
    Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang L, Zhang Y, Zhou B, Zhou ZG, Sun XF.
    Int J Colorectal Dis; 2013 Feb 14; 28(2):183-9. PubMed ID: 22885837
    [Abstract] [Full Text] [Related]

  • 37. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H, Wang C, Hao M, Sun R, Wang Y, Liu T, Cong X, Liu Y.
    Hum Pathol; 2016 Apr 14; 50():101-8. PubMed ID: 26997443
    [Abstract] [Full Text] [Related]

  • 38. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W, Zhao ZY, Shi L, Yuan WD.
    Diagn Pathol; 2015 Jul 21; 10():116. PubMed ID: 26194657
    [Abstract] [Full Text] [Related]

  • 39. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
    Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.
    J Natl Cancer Inst; 2013 Jun 19; 105(12):849-59. PubMed ID: 23704278
    [Abstract] [Full Text] [Related]

  • 40. Clinicopathologic and prognostic relevance of miR-1256 in colorectal cancer: a preliminary clinical study.
    Liu ZY, Yang L, Chang HY.
    Eur Rev Med Pharmacol Sci; 2018 Nov 19; 22(22):7704-7709. PubMed ID: 30536313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.